InvestorsHub Logo
Followers 1
Posts 70
Boards Moderated 0
Alias Born 03/12/2019

Re: None

Wednesday, 08/18/2021 12:44:33 PM

Wednesday, August 18, 2021 12:44:33 PM

Post# of 869
Oral Remdesivir

DEC 2020 RELEASE:

Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology

https://www.globenewswire.com/news-release/2020/12/07/2140383/0/en/Matinas-BioPharma-Announces-Collaboration-with-the-National-Institute-of-Allergy-and-Infectious-Diseases-to-Evaluate-Oral-Formulations-of-Gilead-s-Antiviral-Remdesivir-Utilizing-Ma.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTNB News